Isis and antisense face crucial test without Novartis

被引：0
|
作者：
Alan Dove
机构：
来源：
Nature Biotechnology | 2000年 / 18卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：19 / 19
相关论文
共 50 条
  • [21] ISIS 301012 gene therapy for hypercholesterolemia: Sense, antisense, or nonsense?
    Ito, Matthew K.
    ANNALS OF PHARMACOTHERAPY, 2007, 41 (10) : 1669 - 1678
  • [22] Elan, Isis form antisense R&D pact
    不详
    CHEMICAL & ENGINEERING NEWS, 1999, 77 (16) : 18 - 18
  • [23] Making sense of antisense: ISIS 2302 (alicaforsen) in the treatment of pouchitis
    Fefferman, DS
    Farrell, RJ
    INFLAMMATORY BOWEL DISEASES, 2004, 10 (04) : 487 - 488
  • [24] Extension of Lilly/Isis antisense drug discovery collatoration in cancer
    不详
    DRUG NEWS & PERSPECTIVES, 2004, 17 (04) : 288 - 288
  • [25] A crucial test
    Check, E
    NATURE MEDICINE, 2005, 11 (03) : 243 - 244
  • [26] Face contour is crucial to the fat face illusion
    Sun, Yu-Hao
    Quinn, Paul C.
    Wang, Zhe
    Shi, Huimin
    Zhong, Ming
    Jin, Haiyang
    Ge, Liezhong
    Pascalis, Olivier
    Tanaka, James W.
    Lee, Kang
    PERCEPTION, 2013, 42 (05) : 488 - 494
  • [27] The Hellenistic face of Isis: Cosmic and saviour goddess
    Gasparro, Giulia Sfameni
    Nile into Tiber: Egypt in the Roman World, 2007, 159 : 40 - 72
  • [28] NOVARTIS HEART PILL ACES MAJOR TEST
    不详
    CHEMICAL & ENGINEERING NEWS, 2014, 92 (36) : 14 - 14
  • [29] Drug evaluation: ISIS-301012, an antisense oligonucleotide for the treatment of hypercholesterolemia
    Burnett, John R.
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2006, 8 (05) : 461 - 467
  • [30] Evaluation of Isis Apo(a)Rx, an Antisense Inhibitor to Apolipoprotein(a), in Healthy Volunteers
    Viney, Nick
    Graham, Mark
    Crooke, Rosanne
    Hughes, Steve
    Singleton, Walter
    CIRCULATION, 2013, 128 (22)
12345